Ibuprofen

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, toothache, backache, menstrual cramps, the common cold, muscular aches, and minor pain of arthritis. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be administered according to the following guidelines to ensure safe and effective use.

For adults and children aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed while symptoms persist. In cases where pain or fever does not adequately respond to 1 tablet, a maximum of 2 tablets may be taken. However, it is imperative not to exceed 6 tablets within a 24-hour period unless specifically directed by a healthcare professional.

For children under 12 years of age, it is advised to consult a doctor before administration to determine the appropriate dosage.

Healthcare professionals should emphasize the importance of using the smallest effective dose and adhering strictly to the recommended dosing guidelines to minimize the risk of adverse effects.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children to prevent accidental ingestion. In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222.

Warnings and Precautions

Ibuprofen may cause severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions can include shock, hives, facial swelling, asthma (wheezing), skin reddening, rash, and blisters. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance.

This product contains a nonsteroidal anti-inflammatory drug (NSAID), which carries a risk of severe stomach bleeding. The likelihood of this adverse effect is increased in patients who are 60 years of age or older, have a history of stomach ulcers or bleeding disorders, are taking anticoagulants or steroid medications, consume three or more alcoholic beverages daily while using this product, or exceed the recommended dosage or duration of use.

NSAIDs, excluding aspirin, are associated with an elevated risk of heart attack, heart failure, and stroke, which can be fatal. This risk is heightened when the medication is used in excess of the recommended dosage or for prolonged periods.

Ibuprofen should not be used in individuals who have previously experienced an allergic reaction to any pain reliever or fever reducer, or in the immediate pre- or post-operative period surrounding heart surgery.

Healthcare professionals should be consulted prior to use if the stomach bleeding warning is applicable, if the patient has experienced significant side effects from pain relievers or fever reducers, has a history of gastrointestinal issues such as heartburn, or has pre-existing conditions including high blood pressure, heart disease, liver cirrhosis, kidney disease, or asthma. Additionally, patients taking diuretics should seek medical advice before use.

It is advisable for patients to consult a doctor or pharmacist before using ibuprofen if they are under medical care for any serious condition, are taking aspirin for cardiovascular protection (as ibuprofen may diminish the efficacy of aspirin), or are using any other medications.

When administering this product, it is recommended to take it with food or milk to mitigate potential stomach upset.

Patients should discontinue use and consult a healthcare professional if they experience any signs of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, or persistent stomach pain. Additionally, they should seek medical attention if they exhibit symptoms indicative of heart problems or stroke, including chest pain, difficulty breathing, leg swelling, slurred speech, or unilateral weakness. Other reasons to stop use include worsening pain lasting more than 10 days, the presence of redness or swelling in the affected area, fever that worsens or persists beyond three days, or the emergence of any new symptoms.

For pregnant or breastfeeding individuals, it is crucial to consult a healthcare professional before use. Ibuprofen should be avoided after 20 weeks of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

In the event of an overdose, immediate medical attention should be sought, or contact should be made with a Poison Control Center at 1-800-222-1222.

Side Effects

Patients using ibuprofen may experience a range of adverse reactions, which can be categorized by seriousness and frequency.

Severe allergic reactions have been reported, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions may include shock, hives, facial swelling, asthma (wheezing), skin reddening, rash, and blisters.

The use of ibuprofen is associated with an increased risk of severe stomach bleeding, particularly in patients who are 60 years of age or older, have a history of stomach ulcers or bleeding problems, are taking anticoagulants or steroid medications, consume three or more alcoholic drinks daily, or exceed the recommended dosage or duration of use. Patients should be vigilant for signs of stomach bleeding, which may manifest as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain.

Additionally, the use of nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, has been linked to an elevated risk of heart attack, heart failure, and stroke, which can be fatal. This risk is heightened when the medication is used in excess of the recommended dosage or for prolonged periods.

Patients are advised not to use ibuprofen if they have previously experienced an allergic reaction to any pain reliever or fever reducer, or if they are undergoing heart surgery. It is recommended that patients consult a healthcare provider prior to use if they have a history of stomach problems, high blood pressure, heart disease, liver cirrhosis, kidney disease, or asthma, or if they are taking diuretics or other medications.

While using ibuprofen, it is advisable to take the medication with food or milk to mitigate potential stomach upset. Patients should discontinue use and seek medical attention if they experience any symptoms indicative of serious conditions, such as chest pain, difficulty breathing, leg swelling, slurred speech, weakness on one side of the body, worsening pain lasting more than 10 days, redness or swelling in the painful area, or fever persisting beyond three days. Any new symptoms that arise should also prompt a consultation with a healthcare professional.

Drug Interactions

Ibuprofen may interact with several classes of medications, leading to significant clinical effects that warrant careful consideration.

Interactions with Antiplatelet Agents Ibuprofen has the potential to diminish the cardioprotective effects of aspirin when both medications are used concurrently for the prevention of heart attack or stroke. It is advisable for patients to avoid the simultaneous use of ibuprofen and aspirin for these indications to ensure optimal therapeutic outcomes.

Interactions with Anticoagulants and Corticosteroids The concomitant use of ibuprofen with anticoagulants or corticosteroids increases the risk of gastrointestinal bleeding. Healthcare providers should monitor patients closely for signs of bleeding and consider alternative pain management strategies or dosage adjustments as necessary.

Interactions with Other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) The use of ibuprofen alongside other NSAIDs, whether prescription or over-the-counter (such as aspirin or naproxen), heightens the risk of gastrointestinal bleeding. It is recommended that patients refrain from using multiple NSAIDs simultaneously to mitigate this risk.

Interactions with Diuretics Patients who are on diuretic therapy should seek medical advice prior to initiating ibuprofen. The combination may necessitate dosage adjustments or increased monitoring to prevent potential adverse effects.

Packaging & NDC

Below are the non-prescription pack sizes of Ibuprofen. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed while symptoms persist. If pain or fever does not adequately respond to 1 tablet, a dose of 2 tablets may be administered. It is important to note that the maximum dosage should not exceed 6 tablets in a 24-hour period unless directed by a healthcare provider.

Geriatric Use

Elderly patients, defined as those aged 65 and older, may experience an increased risk of severe stomach bleeding, particularly if they are 60 years of age or older. The likelihood of adverse cardiovascular events, including heart attack, heart failure, and stroke, is heightened in this population, especially when the medication is used in excess of the recommended dosage or for prolonged periods.

To mitigate gastrointestinal discomfort, it is advisable for elderly patients to take the medication with food or milk, as they may have more sensitive stomachs. In the event of any signs of stomach bleeding, it is crucial for elderly patients to discontinue use and consult a healthcare provider, as the implications of such symptoms can be more severe in this demographic.

Furthermore, caution is warranted for elderly patients with a history of gastrointestinal issues, hypertension, heart disease, liver cirrhosis, kidney disease, or asthma, as these conditions are more prevalent in older adults and may exacerbate the risks associated with the medication.

When prescribing for geriatric patients, it is recommended to utilize the smallest effective dose to minimize the potential for side effects, given their increased sensitivity to medications. Regular monitoring and careful consideration of these factors are essential to ensure the safe use of the medication in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. It is particularly important to avoid the use of ibuprofen after 20 weeks of pregnancy unless specifically directed by a physician, as it may pose risks to the developing fetus and lead to complications during delivery. Healthcare providers should carefully evaluate the potential benefits and risks when considering the use of this medication in pregnant patients.

Lactation

Lactating mothers are advised to consult a health professional before using this medication while breastfeeding. It is particularly important to avoid the use of ibuprofen at 20 weeks of gestation or later unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data provided regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare providers should weigh the potential benefits against the risks when considering this medication for lactating mothers.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have conditions such as high blood pressure, heart disease, liver cirrhosis, or asthma. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the degree of kidney impairment.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to use, particularly if they have conditions such as liver cirrhosis. It is essential for these patients to receive appropriate medical guidance to assess the potential risks and benefits associated with the use of this medication. Monitoring of liver function may be necessary to ensure safety and efficacy in this population. Adjustments to dosage or treatment regimens may be required based on the severity of hepatic impairment and the patient's overall health status.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt action is crucial to mitigate potential adverse effects associated with overdosage.

Healthcare professionals should be aware that symptoms of overdose may vary depending on the specific substance involved. Therefore, a thorough assessment of the patient's condition is essential.

Management of an overdose typically involves supportive care and symptomatic treatment. It is recommended that healthcare providers monitor the patient closely for any signs of toxicity and initiate appropriate interventions based on the clinical presentation.

In summary, timely medical intervention and appropriate management strategies are vital in addressing the complications arising from an overdose.

Nonclinical Toxicology

It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no details regarding nonclinical toxicology or animal pharmacology and toxicology provided in the text.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions reported voluntarily or through surveillance programs.

Allergic reactions, including anaphylaxis, have been documented. Serious skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have also been reported. Cardiovascular events, including myocardial infarction and stroke, have been noted in the postmarketing data.

Gastrointestinal adverse events, including gastrointestinal bleeding and ulceration, have been observed. Additionally, renal adverse events, such as acute renal failure, have been reported. Hepatic adverse events, including elevations in liver enzymes and cases of hepatitis, have also been identified.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of safety in the home environment, particularly for households with young children.

In the event of an overdose, healthcare providers should instruct patients to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222. Patients should be made aware of the potential seriousness of an overdose and the importance of prompt action.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature between 20°-25°C (68°-77°F). Care should be taken to avoid exposure to excessive heat, specifically temperatures exceeding 40°C (104°F). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid ibuprofen after 20 weeks of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

Drug Information (PDF)

This file contains official product information for Ibuprofen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)